Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Securinine and norsecurinine analogue compounds for the treatment of myeloid disorders

Securinine and norsecurinine analogue compounds for the treatment of myeloid disorders

US Patent 10130616 · Granted Nov 20, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Water soluble antiviral and antimicrobial compound and process for preparation t2025
Event triggered network migration of subscribers2024
Compositions for expanding natural killer cells2024
Event triggered network migration of subscribers2024
System and method for calculating agent skill satisfaction index and utilization2023
System and method for calculating agent skill satisfaction index and utilization2023
Restricting communication using operator determined barring2021
Automated preparation of breads2021
Securinine and norsecurinine analogue compounds for the treatment of myeloid dis2020
Securinine and norsecurinine analogue compounds for the treatment of myeloid dis2020
Securinine and norsecurinine analogue compounds for the treatment of myeloid dis2020
Securinine and norsecurinine analogue compounds for the treatment of myeloid dis2020